Catherine M. Gordon

ORCID: 0000-0001-8988-7186 · 11 papers in corpus · active 1998-2025

Study types

  • article 11

Condition tags

  • endometriosis 10
article 2025
Effect of Transdermal Estrogen Therapy on Bone and Neurobehavioral Health in Youth with Premature Ovarian Insufficiency: A Case-Control Study
·doi:10.1016/j.jpag.2025.03.005
article 2018
Long-Term Effects of Gonadotropin-Releasing Hormone Agonist and Add-Back in Adolescent Endometriosis
·doi:10.1016/j.jpag.2018.02.074
article 2018
Long-Term Effects of Gonadotropin-Releasing Hormone Agonists and Add-Back in Adolescent Endometriosis
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2018.03.004
article 2016
The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2016.02.008
article 2015
45. The Effect of Hormonal Add-back Therapy in Adolescents Treated With a Gonadotropin Releasing Hormone (GnRH) Agonist for Endometriosis: A Randomized Trial
·doi:10.1016/j.jadohealth.2014.10.049
article 2015
Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis
·doi:10.1097/ogx.0000000000000249

Endometriosis often begins during adolescence. Appropriate management includes prompt initiation of therapy and long-term maintenance therapy. Gonadotropin-releasing hormone (GnRH) agonists are commonly used second-line therapy for patients…

article 2015
Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis
Obstetrics and gynecology ·doi:10.1097/aog.0000000000000964

OBJECTIVE: To assess whether add-back therapy with norethindrone acetate or norethindrone acetate plus conjugated equine estrogens is superior to maintain bone health in adolescents and young women using gonadotropin-releasing hormone agoni…

article 2015
The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a Gonadotropin Releasing Hormone (GnRH) Agonist for Endometriosis: A Randomized Trial
·doi:10.1016/j.jpag.2015.02.008
article 2007
Bone Density in Adolescents Treated with a GnRH Agonist and Add-Back Therapy for Endometriosis
Journal of Pediatric and Adolescent Gynecology ·doi:10.1016/j.jpag.2007.04.008
article 2006
Preservation of Bone Mineral Density in Adolescents Treated with GnRH Agonists and Add-Back Therapy for Endometriosis
·doi:10.1016/j.jpag.2006.01.021
article 1998
"Add-back" therapy for endometriosis in adolescents.
The Journal of reproductive medicine

OBJECTIVE: To review the impact of gonadotropin-releasing hormone agonists (GnRH-as) on bone mass in adolescents and options for GnRH-a with "add-back" for long-term therapy for adolescents with endometriosis not responding to conventional …